Kanti Pabbaraju1, Sallene Wong2, Kara Gill3, Kevin Fonseca4, Graham A Tipples5, Raymond Tellier6. 1. Provincial Laboratory for Public Health, Calgary, Alberta, Canada. Electronic address: kanti.pabbaraju@ahs.ca. 2. Provincial Laboratory for Public Health, Calgary, Alberta, Canada. Electronic address: sallene.wong@ahs.ca. 3. Provincial Laboratory for Public Health, Calgary, Alberta, Canada. Electronic address: kara.gill2@ahs.ca. 4. Provincial Laboratory for Public Health, Calgary, Alberta, Canada; Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Alberta, Canada University of Calgary, Alberta, Canada. Electronic address: kevin.fonseca@ahs.ca. 5. Provincial Laboratory for Public Health, Calgary, Alberta, Canada; Department of Pathology and Laboratory Medicine, University of Alberta, Edmonton, Alberta, Canada. Electronic address: graham.tipples@ahs.ca. 6. Provincial Laboratory for Public Health, Calgary, Alberta, Canada; Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Alberta, Canada University of Calgary, Alberta, Canada. Electronic address: raymond.tellier@ahs.ca.
Abstract
BACKGROUND: In the recent past, arboviruses such as Chikungunya (CHIKV) and Zika (ZIKV) have increased their area of endemicity and presented as an emerging global public health threat. OBJECTIVES: To design an assay for the simultaneous detection of ZIKV, CHIKV and Dengue (DENV) 1-4 from patients with symptoms of arboviral infection. This would be advantageous because of the similar clinical presentation typically encountered with these viruses and their co-circulation in endemic areas. STUDY DESIGN: In this study we have developed and validated a triplex real time reverse transcription PCR assay using hydrolysis probes targeting the non-structural 5 (NS5) region of ZIKV, non-structural protein 4 (nsP4) from CHIKV and 3' untranslated region (3'UTR) of DENV 1-4. RESULTS AND CONCLUSIONS: The 95% LOD by the triplex assay was 15 copies/reaction for DENV-1 and less than 10 copies/reaction for all other viruses. The triplex assay was 100% specific and did not amplify any of the other viruses tested. The assay was reproducible and adaptable to testing different specimen types including serum, plasma, urine, placental tissue, brain tissue and amniotic fluid. This assay can be easily implemented for diagnostic testing of patient samples, even in a high throughput laboratory.
BACKGROUND: In the recent past, arboviruses such as Chikungunya (CHIKV) and Zika (ZIKV) have increased their area of endemicity and presented as an emerging global public health threat. OBJECTIVES: To design an assay for the simultaneous detection of ZIKV, CHIKV and Dengue (DENV) 1-4 from patients with symptoms of arboviral infection. This would be advantageous because of the similar clinical presentation typically encountered with these viruses and their co-circulation in endemic areas. STUDY DESIGN: In this study we have developed and validated a triplex real time reverse transcription PCR assay using hydrolysis probes targeting the non-structural 5 (NS5) region of ZIKV, non-structural protein 4 (nsP4) from CHIKV and 3' untranslated region (3'UTR) of DENV 1-4. RESULTS AND CONCLUSIONS: The 95% LOD by the triplex assay was 15 copies/reaction for DENV-1 and less than 10 copies/reaction for all other viruses. The triplex assay was 100% specific and did not amplify any of the other viruses tested. The assay was reproducible and adaptable to testing different specimen types including serum, plasma, urine, placental tissue, brain tissue and amniotic fluid. This assay can be easily implemented for diagnostic testing of patient samples, even in a high throughput laboratory.
Authors: Nischay Mishra; James Ng; Jennifer L Rakeman; Michael J Perry; Dominick A Centurioni; Amy B Dean; Adam Price; Riddhi Thakkar; Andreina Garcia Angus; Phillip Williamson; Eric Delwart; Christine Carrington; Nikita Sahadeo; Xiaoyu Che; Thomas Briese; Rafal Tokarz; W Ian Lipkin Journal: J Clin Virol Date: 2019-09-16 Impact factor: 3.168
Authors: Gilberto A Eskildsen; Laura D Kramer; Steven D Zink; Alan P Dupuis; Susan J Wong; Andrea Furuya; Jose R Loaiza Journal: Am J Trop Med Hyg Date: 2020-05 Impact factor: 2.345
Authors: Ozlem Yaren; Barry W Alto; Kevin M Bradley; Patricia Moussatche; Lyudmyla Glushakova; Steven A Benner Journal: J Vis Exp Date: 2018-03-13 Impact factor: 1.355